Nepafenac 0.3% ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nepafenac 0.3% ophthalmic suspension, covering 2021-02-16 to 2021-02-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension [Phase 3]